Analyst Consensus ?
ConsensusHold29 ratings
Bullish724.1%
Neutral1655.2%
Bearish620.7%
FN2 Earnings Intelligence
Moderna, Inc. analyst ratings
Moderna, Inc. (MRNA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$214.16Previous close
$15Low
$119.39Average
$350High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 29, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| William Blair | Market Perform | Outperform | Downgrade | Oct 27, 2026 |
| Piper Sandler | Overweight | Overweight | Maintain | Oct 26, 2026 |
| TD Cowen | Hold | Hold | Maintain | Oct 21, 2026 |
| Goldman Sachs | Neutral | Neutral | Maintain | Oct 15, 2026 |
| Morgan Stanley | Equal Weight | Equal Weight | Maintain | Oct 7, 2026 |
| Citigroup | Sell | Neutral | Downgrade | Sep 30, 2026 |
| Rothschild & Co | Sell | Neutral | Downgrade | Sep 3, 2026 |
| Argus Research | Buy | Hold | Upgrade | Aug 28, 2026 |
| Wolfe Research | Peer Perform | Underperform | Upgrade | Aug 25, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Aug 24, 2026 |
| JP Morgan | Underweight | Underweight | Maintain | Aug 21, 2026 |
| UBS | Neutral | Neutral | Maintain | Aug 20, 2026 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jul 7, 2026 |
| B of A Securities | Underperform | Underperform | Maintain | Jul 7, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | May 4, 2026 |
| Leerink Partners | Underperform | Underperform | Maintain | Nov 21, 2025 |
| Needham | Hold | Hold | Maintain | Oct 20, 2025 |
| HSBC | Buy | Hold | Upgrade | Nov 18, 2024 |
| Deutsche Bank | Hold | Sell | Upgrade | Aug 6, 2024 |
| Oppenheimer | Outperform | Outperform | Maintain | Jun 12, 2024 |
| Canaccord Genuity | Hold | Hold | Maintain | May 3, 2024 |
| Jefferies | Buy | Buy | Maintain | Apr 9, 2024 |
| Guggenheim | Neutral | Neutral | Maintain | Apr 26, 2023 |
| SVB Leerink | Underperform | Market Perform | Downgrade | Feb 24, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Jan 25, 2023 |
| Chardan Capital | Neutral | Neutral | Maintain | Jan 18, 2023 |
| Brookline Capital | Buy | Buy | Maintain | Feb 26, 2021 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Feb 1, 2021 |
| BMO Capital | Outperform | Outperform | Maintain | Nov 25, 2020 |
Named analyst price targets
Upside is calculated against the persisted previous close $214.16. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Piper Sandler | Analyst unavailable | $230 | $200.1 | +7.4% | Oct 26, 2026 |
| Goldman Sachs | Salveen Richter | $137 | $226.3 | -36.0% | Oct 15, 2026 |
| UBS | Analyst unavailable | $81 | $150.81 | -62.2% | Sep 3, 2026 |
| Argus Research | John Eade | $180 | $142.77 | -16.0% | Aug 28, 2026 |
| Barclays | Eliana Merle | $125 | $145.13 | -41.6% | Aug 24, 2026 |
| UBS | Michael Yee | $150 | $174.38 | -30.0% | Aug 20, 2026 |
| Goldman Sachs | Analyst unavailable | $120 | $174.38 | -44.0% | Aug 19, 2026 |
| RBC Capital | Luca Issi | $130 | $151.3 | -39.3% | Aug 19, 2026 |
| Loop Capital Markets | Leah Rush Cann | $135 | $139.12 | -37.0% | Aug 19, 2026 |
| D.A. Davidson | Michael Baker | $245 | $138.2 | +14.4% | Aug 19, 2026 |
| Goldman Sachs | Analyst unavailable | $67 | $59.49 | -68.7% | Jul 21, 2026 |
| Wolfe Research | Alexandria Hammond | $25 | $61.82 | -88.3% | Jul 20, 2026 |
| Morgan Stanley | Analyst unavailable | $39 | $79.77 | -81.8% | Jul 8, 2026 |
| RBC Capital | Analyst unavailable | $45 | $81.8 | -79.0% | Jul 7, 2026 |
| Piper Sandler | Analyst unavailable | $77 | $67.66 | -64.0% | Jun 26, 2026 |
| UBS | Analyst unavailable | $45 | $47.46 | -79.0% | May 4, 2026 |
| RBC Capital | Luca Issi | $38 | $46.87 | -82.3% | May 4, 2026 |
| Goldman Sachs | Analyst unavailable | $49 | $45.37 | -77.1% | May 1, 2026 |
| Morgan Stanley | Analyst unavailable | $33 | $44.18 | -84.6% | May 1, 2026 |
| Jefferies | Andrew Tsai | $37 | $49.83 | -82.7% | Mar 3, 2026 |
| RBC Capital | Luca Issi | $30 | $42.54 | -86.0% | Feb 17, 2026 |
| Evercore ISI | Cory Kasimov | $35 | $43.19 | -83.7% | Feb 17, 2026 |
| Bernstein | Analyst unavailable | $45 | $42.23 | -79.0% | Feb 17, 2026 |
| UBS | Analyst unavailable | $36 | $42.23 | -83.2% | Feb 16, 2026 |
| Morgan Stanley | Analyst unavailable | $30 | $42.23 | -86.0% | Feb 16, 2026 |
| UBS | Analyst unavailable | $34 | $35.66 | -84.1% | Jan 6, 2026 |
| Morgan Stanley | Analyst unavailable | $28 | $29.9 | -86.9% | Dec 12, 2025 |
| Jefferies | Analyst unavailable | $30 | $29.62 | -86.0% | Dec 12, 2025 |
| RBC Capital | Luca Issi | $25 | $23.1 | -88.3% | Nov 21, 2025 |
| UBS | Analyst unavailable | $18 | $22.36 | -91.6% | Nov 21, 2025 |
| Piper Sandler | Analyst unavailable | $63 | $22.36 | -70.6% | Nov 21, 2025 |
| Wolfe Research | Analyst unavailable | $17 | $22.36 | -92.1% | Nov 20, 2025 |
| Berenberg Bank | Analyst unavailable | $28 | $24.77 | -86.9% | Nov 17, 2025 |
| UBS | Analyst unavailable | $40 | $26.85 | -81.3% | Oct 23, 2025 |
| Leerink Partners | Analyst unavailable | $15 | $27.12 | -93.0% | Aug 22, 2025 |
| J.P. Morgan | Jessica Fye | $26 | $29.56 | -87.9% | Aug 1, 2025 |
| Evercore ISI | Cory Kaimov | $50 | $31.92 | -76.7% | Feb 14, 2025 |
| Piper Sandler | Edward Tenthoff | $69 | $37.27 | -67.8% | Nov 18, 2024 |
| HSBC | Yifeng Liu | $58 | $84.93 | -72.9% | Nov 18, 2024 |
| Bernstein | Courtney Breen | $55 | $57.46 | -74.3% | Oct 17, 2024 |
| Jefferies | Michael Yee | $55 | $57.73 | -74.3% | Oct 14, 2024 |
| Piper Sandler | Edward Tenthoff | $115 | $69.68 | -46.3% | Sep 13, 2024 |
| RBC Capital | Luca Issi | $75 | $69.68 | -65.0% | Sep 13, 2024 |
| Loop Capital Markets | Leah Rush Cann | $238 | $69.68 | +11.1% | Sep 13, 2024 |
| Jefferies | Michael Yee | $65 | $69.68 | -69.6% | Sep 12, 2024 |
| Evercore ISI | Cory Kasimov | $105 | $67.68 | -51.0% | Sep 12, 2024 |
| Morgan Stanley | Matthew Harrison | $94 | $67.51 | -56.1% | Sep 12, 2024 |
| Jefferies | Michael Yee | $120 | $67.52 | -44.0% | Sep 12, 2024 |
| Robert W. Baird | Peter Arment | $220 | $78.52 | +2.7% | Aug 28, 2024 |
| HSBC | Yifeng Liu | $82 | $78.98 | -61.7% | Aug 28, 2024 |
| Deutsche Bank | Emmanuel Papadakis | $80 | $82.3 | -62.6% | Aug 6, 2024 |
| RBC Capital | Luca Issi | $90 | $86.58 | -58.0% | Aug 5, 2024 |
| Piper Sandler | Edward Tenthoff | $157 | $90.03 | -26.7% | Aug 2, 2024 |
| Oppenheimer | Hartaj Singh | $179 | $148.39 | -16.4% | Jun 12, 2024 |
| Loop Capital Markets | Leah Rush Cann | $310 | $147.47 | +44.7% | Jun 10, 2024 |
| Jefferies | Michael Yee | $180 | $152.03 | -16.0% | Jun 7, 2024 |
| RBC Capital | Luca Issi | $160 | $141.83 | -25.3% | May 31, 2024 |
| Evercore ISI | Cory Kasimov | $120 | $125.67 | -44.0% | May 13, 2024 |
| Deutsche Bank | Emmanuel Papadakis | $85 | $124.06 | -60.3% | May 9, 2024 |
| UBS | Eliana Merle | $151 | $122.13 | -29.5% | May 7, 2024 |
| Jefferies | Michael Yee | $155 | $123.02 | -27.6% | May 3, 2024 |
| Canaccord Genuity | Bill Maughan | $106 | $125.59 | -50.5% | May 3, 2024 |
| Oppenheimer | Hartaj Singh | $163 | $125.59 | -23.9% | May 3, 2024 |
| RBC Capital | Luca Issi | $135 | $125.59 | -37.0% | May 3, 2024 |
| Morgan Stanley | Matthew Harrison | $95 | $125 | -55.6% | May 2, 2024 |
| Morgan Stanley | Matthew Harrison | $89 | $108.85 | -58.4% | Apr 24, 2024 |
| Jefferies | Michael Yee | $125 | $110.59 | -41.6% | Mar 28, 2024 |
| UBS | Eliana Merle | $143 | $107.41 | -33.2% | Mar 27, 2024 |
| Morgan Stanley | Matthew Harrison | $123 | $87.59 | -42.6% | Feb 22, 2024 |
| Oppenheimer | Hartaj Singh | $142 | $113.15 | -33.7% | Jan 2, 2024 |
| UBS | Eliana Merle | $191 | $121.14 | -10.8% | Jun 26, 2023 |
| Piper Sandler | Analyst unavailable | $217 | $189.89 | +1.3% | Dec 20, 2022 |
| Jefferies | Analyst unavailable | $275 | $193.29 | +28.4% | Dec 19, 2022 |
| Morgan Stanley | Analyst unavailable | $209 | $191.78 | -2.4% | Dec 16, 2022 |
| Chardan Capital | Analyst unavailable | $191 | $212.4 | -10.8% | Dec 14, 2022 |
| Leerink Partners | Analyst unavailable | $102 | $197.54 | -52.4% | Dec 13, 2022 |
| Argus Research | Jasper Hellweg Hellweg | $150 | $123.64 | -30.0% | Sep 24, 2022 |
| Piper Sandler | Edward Tenthoff | $214 | $142.28 | -0.1% | May 17, 2022 |
| Morgan Stanley | Matthew Harrison | $199 | $155.05 | -7.1% | May 4, 2022 |
| Piper Sandler | Edward Tenthoff | $348 | $176.59 | +62.5% | Apr 1, 2022 |
| Morgan Stanley | Matthew Harrison | $205 | $173.08 | -4.3% | Mar 28, 2022 |
| Deutsche Bank | Emmanuel Papadakis | $155 | $129.28 | -27.6% | Mar 8, 2022 |
| Jefferies | Michael Yee | $170 | $151.33 | -20.6% | Feb 27, 2022 |
| Barclays | Gena Wang | $210 | $156.23 | -1.9% | Feb 24, 2022 |
| Cowen & Co. | Tyler Van Buren | $200 | $172.74 | -6.6% | Feb 1, 2022 |
| Deutsche Bank | Emmanuel Papadakis | $175 | $154.96 | -18.3% | Jan 26, 2022 |
| UBS | Eliana Merle | $221 | $160.07 | +3.2% | Jan 21, 2022 |
| Argus Research | Jasper Hellweg | $350 | $216.06 | +63.4% | Jan 6, 2022 |
| Wolfe Research | Andrew Galler | $304 | $244.68 | +41.9% | Nov 8, 2021 |
| J.P. Morgan | Cory Kasimov | $165 | $284.02 | -23.0% | Nov 4, 2021 |
| Wells Fargo | Nick Abbott | $145 | $234.46 | -32.3% | Jun 29, 2021 |
| Chardan Capital | Geulah Livshits | $188 | $185.01 | -12.2% | May 28, 2021 |
Track every rating change on MRNA the moment it posts. Free to start.
Start freeGet the MRNA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.